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Overexpression of Amphiregulin in the Epidermis of
Transgenic Mice Induces a Psoriasis-Like Cutaneous
Phenotype
To the Editor: speculated that wound-induced AR expression may be involved
in the pathogenesis of lesion formation, and in triggering lesion
formation in patients with psoriasis that display the KoebnerIt has come to our attention that the review article entitled ‘‘Animal
(isomorphic) response (Cook et al, 1997; Piepkorn et al, 1998).models of psoriasis – what can we learn from them’’ by Dr Michael
Thus cutaneous events initiating or mimicking abnormal woundP. Scho¨n (Scho¨n, 1999), which was published recently in the Journal
re-epithelialization or barrier disruption responses (e.g., perturbedof Investigative Dermatology, has omitted mentioning what we believe
AR expression, defective S-gene expression) may emerge as ato be an important transgenic psoriasis-like mouse model. This
common pathway to psoriatic lesion formation.model, in which we have overexpressed the heparin-binding EGF-
related ligand Amphiregulin (AR) in the epidermis, produces a
Paul W. Cook, Mark R. Pittelkow,* Michael Piepkorn†cutaneous phenotype that strongly resembles psoriasis and was first
Department of Dermatology, Oregon Health Sciences University,reported by our research group in November 1997 (Cook et al,
Portland, Oregon, U.S.A.1997). In this mouse model, transgenic mice with a K14 enhancer/
*Department of Dermatology, The Mayo Medical School/Clinicpromoter-driven AR gene targeted to the epidermis displayed a
Rochester, Minnesota, U.S.A.macroscopic phenotype that included extensive areas of scaling and
†Department of Medicine, Division of Dermatology, Universityerythematous skin with marked alopecia. Moreover, histologic
of Washington Medical Center, Seattle, Washington, U.S.A.examination of these AR-expressing mice also revealed hyper-
keratosis, focal parakeratosis, acanthosis, mixed leukocytic REFERENCESinfiltration that included both CD3-positive T cells and neutrophils
Allen MH, Veal C, Faassen A, Powis SH, Vaughan RW, Trembath RC, Barkerin the dermis and epidermis, and a tortuous dermal vasculature.
JN: A non-HLA gene within the MHC in psoriasis. Lancet 353:1589–1590, 1999We have concluded that our results reveal AR to exert activities Cook PW, Piepkorn M, Clegg CH, Plowman GD, Demay JM, Brown JR, Pittelkow
in the skin that are distinct (e.g., leukocytic infiltration) from MR: Transgenic expression of the human amphiregulin gene induces a
psoriasis-like phenotype. J Clin Invest 100:2286–2294, 1997another transgenic EGF-ligand (transforming growth factor-α), or
Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ, Shipleyother cytokines. Furthermore, aberrant overexpression of AR might
GD: Amphiregulin messenger RNA is elevated in psoriatic epidermis andbe involved in the pathophysiology of psoriasis as we and colleagues gastrointestinal carcinomas. Cancer Res 52:3224–3227, 1992
have shown that it is consistently overexpressed in involved psoriatic Elder JT, Xia L-Q, Majmudar G, Johnson T: Selective overexpression of amphiregulin
in cutaneous squamous and basal cell carcinoma. J Invest Derm 100:492a, 1993epidermis, when compared with normal or uninvolved epidermis
Hardas B, Yang Q, Elder JT: Regulation of amphiregulin, a heparin-binding, EGF-(Cook et al, 1992; Hardas et al, 1992; Elder et al, 1993; Stoll et al,
like growth factor, in human skin. J Invest Derm 98:575a, 19921994; Piepkorn, 1996). Liou A, Elias PM, Grunfeld C, Feingold KR, Wood LC: Amphiregulin and nerve
Recent observations have also implicated the non-HLA keratino- growth factor expression are regulated by barrier status in murine epidermis.
J Invest Derm 108:73–77, 1997cyte structural ‘‘S’’ or corneodesmosin gene as a potential psoriasis
Piepkorn M: Overexpression of amphiregulin, a major autocrine growth factor forsusceptibility gene located in close proximity to the MHC region
cultured human keratinocytes, in hyperproliferative skin diseases. J Dermatopatholof human chromosome 6 (Allen et al, 1999; Zhou and Chaplin, 18:165–171, 1996
1993; Tazi Ahnini et al, 1999). It has been speculated that defects Piepkorn M, Pittelkow MR, Cook PW: Autocrine regulation of keratinocytes: the
emerging role of heparin-binding, epidermal growth factor-related growthin the function of the corneodesmosin differentiation antigen could
factors. J Invest Derm 111:715–721, 1998lead to barrier disruption and initiate increased susceptibility to
Scho¨n MP: Animal models of psoriasis – what can we learn from them? J Invest
psoriatic lesion formation (Allen et al, 1999). Because recent reports Derm 112:405–410, 1999
have implicated AR as a wounding- or barrier disruption-associated Stoll S, Garner W, Elder JT: Heparin-binding ligands mediate autocrine epidermal
growth factor receptor activation in skin organ culture. J Clin Invest 100:1271–factor (Liou et al, 1997; Stoll et al, 1997), we have therefore
1281, 1997
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